425 filed Jul 20, 2026 at 17:20 ET
Tempus AI (TEM) filed an investor presentation deck as a Rule 425 communication, reinforcing its July 20, 2026 announcement to acquire Personalis (PSNL) for $16.25/share in a stock-for-stock transaction valued at $1.7Bn ($1.5Bn net of Tempus's existing stake). The presentation emphasizes the strategic rationale of integrating Personalis's ultrasensitive MRD technology into Tempus's AI-enabled precision oncology platform, targeting a >$20B market opportunity, and highlights Personalis's Q2 test volume of 10,384 (33% sequential growth) and >35,000 total tests delivered. The deal is expected to close in Q4 2026, subject to Personalis shareholder approval and regulatory clearances.